Connective tissue growth factor (CTGF/CCN2) ELISA: A novel tool for monitoring fibrosis

Biomarkers

Volumn 16, Issue 4, 2011, Pages 289-301

  Dendooven, Amélie ^a   Gerritsen, Karin G ^a   Nguyen, Tri Q ^a   Kok, Robbert J ^b   Goldschmeding, Roel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

biomarker; Connective tissue growth factor; fibrosis; sandwich ELISA

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE; LIPOPROTEIN RECEPTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

BIBLIOGRAPHIC DATABASE; BILE DUCT ATRESIA; CARCINOID SYNDROME; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSIS; HEART FAILURE; HEART MUSCLE FIBROSIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL LUNG DISEASE; KIDNEY TRANSPLANTATION; LIVER FIBROSIS; MACROALBUMINURIA; NEPHROSCLEROSIS; NONHUMAN; OUTCOME ASSESSMENT; PATIENT MONITORING; PORTAL HYPERTENSION; PROTEIN BLOOD LEVEL; REVIEW; SCLERODERMA; SYSTEMIC SCLEROSIS;

ANIMALS; BIOLOGICAL MARKERS; CONNECTIVE TISSUE GROWTH FACTOR; DATA COLLECTION; DATABASES, BIBLIOGRAPHIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROSIS; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 79957471970     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.561366     Document Type: Review

References (89)

1. Abraham D. (2008). Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Rheumatology (Oxford) 47 (Suppl 5):8-9.
2. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. (2002). Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4:599-604.
3. Ahmed MS, øie E, Vinge LE, Yndestad A, øystein Andersen G, Andersson Y, Attramadal T, Attramadal H. (2004). Connective tissue growth factor-a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol 36:393-404. (Pubitemid 38316944)
4. Allen JT, Knight RA, Bloor CA, Spiteri MA. (1999). Enhanced insulinlike growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol 21:693-700. (Pubitemid 129502288)
5. Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH. (2005). Reduction of urinary connective tissue growth factor by losartan in type 1 patients with diabetic nephropathy. Kidney Int 67:2325-2329. (Pubitemid 41623393)
6. Aoyama E, Hattori T, Hoshijima M, Araki D, Nishida T, Kubota S, Takigawa M. (2009). N-terminal domains of CCN family 2/ connective tissue growth factor bind to aggrecan. Biochem J 420:413-420.
7. Bao J, Tu Z, Wang J, Ye F, Sun H, Qin M, Shi Y, Bu H, Li YP. (2008). A novel accurate rapid ELISA for detection of urinary connective tissue growth factor, a biomarker of chronic allograft nephropathy. Transplant Proc 40:2361-2364.
8. Bergestuen DS, Gravning J, Haugaa KH, Sahakyan LG, Aakhus S, Thiis- Evensen E, øie E, Aukrust P, Attramadal H, Edvardsen T. (2010). Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors. BMC Cancer 10:6.
9. Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR, Harding PA. (1997). Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparinregulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem 272:20275-20282. (Pubitemid 27340141)
10. Chen CC, Lau LF. (2009). Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41:771-783.
11. Cheng O, Thuillier R, Sampson E, Schultz G, Ruiz P, Zhang X, Yuen PS, Mannon RB. (2006). Connective growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 6:2292-2306. (Pubitemid 44359414)
12. Cicha I, Garlichs CD, Daniel WG, Goppelt-Struebe M. (2004). Activated human platelets release connective tissue growth factor. Thromb Haemost 91:755-760. (Pubitemid 38477456)
13. Cicha I, Goppelt-Struebe M. (2009). Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors 35:200-208.
14. Cicha I, Yilmaz A, Klein M, Raithel D, Brigstock DR, Daniel WG, Goppelt-Struebe M, Garlichs CD. (2005). Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol 25:1008-1013. (Pubitemid 40627847)
15. Dziadzio M, Usinger W, Leask A, Abraham D, Black CM, Denton C, Stratton R. (2005). N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM 98:485-492. (Pubitemid 41418671)
16. Fletcher JT, Nankivell BJ, Alexander SI. (2009). Chronic allograft nephropathy. Pediatr Nephrol 24:1465-1471.
17. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, Spagnolo P, Pantelidis P, Leoni P, McHugh N, Stock CJ, Shi- Wen X, Denton CP, Black CM, Welsh KI, du Bois RM, Abraham DJ. (2007). A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 357:1210-1220. (Pubitemid 47443180)
18. Gao R, Brigstock DR. (2004). Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279:8848-8855. (Pubitemid 38295943)
19. Gao R, Brigstock DR. (2003). Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 27:214-220. (Pubitemid 37407669)
20. Gerritsen KG, Peters HP, Nguyen TQ, Koeners MP, Wetzels JF, Joles JA, Christensen EI, Verroust PJ, Li D, Oliver N, Xu L, Kok RJ, Goldschmeding R. (2010). Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion. Am J Physiol Renal Physiol 298:F1457-F1464.
21. Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G. (2003). Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Diabetes Care 26:2632-2636. (Pubitemid 37052112)
22. Granel B, Argiro L, Hachulla E, Fajardy I, Weiller PJ, Durand JM, Frances Y, Dombey AM, Marquet S, Lesavre N, Disdier P, Bernard F, Hatron PY, Chevillard C. (2010). Association between a CTGF gene polymorphism and systemic sclerosis in a French population. J Rheumatol 37:351-358.
23. Gressner AM, Yagmur E, Lahme B, Gressner O, Stanzel S. (2006). Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem 52:1815-1817. (Pubitemid 44330719)
24. Grotendorst GR, Duncan MR. (2005). Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19:729-738. (Pubitemid 40617377)
25. Guo-Qiu W, Nai-Feng L, Xiao-Bo V, Linxian L, Chen Z, Lixia G, Zhao L. (2010). The level of connective tissue growth factor in sera of patients with hepatitis B virus strongly correlates with stage of hepatic fibrosis. Viral Immunol 23:71-78.
26. Heng EC, Huang Y, Black SA Jr, Trackman PC. (2006). CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins. J Cell Biochem 98:409-420.
27. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH. (2004). Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 287:F1223-F1232. (Pubitemid 39507231)
28. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C. (1994). Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 37:278-288.
29. Hinton DR, Spee C, He S, Weitz S, Usinger W, LaBree L, Oliver N, Lim JI. (2004). Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care 27:758-764. (Pubitemid 38280546)
30. Hoshijima M, Hattori T, Inoue M, Araki D, Hanagata H, Miyauchi A, Takigawa M. (2006). CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett 580:1376-1382. (Pubitemid 43222004)
31. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K. (1996). Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729-733. (Pubitemid 26119731)
32. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K, Okada Y. (2002). Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 16:219-221.
33. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R. (1998). Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861. (Pubitemid 28155657)
34. Ito Y, Aten J, Nguyen TQ, Joles JA, Matsuo S, Weening JJ, Goldschmeding R. (2010). Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol 117:e9-20.
35. Iwanciw D, Rehm M, Porst M, Goppelt-Struebe M. (2003). Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways. Arterioscler Thromb Vasc Biol 23:1782-1787. (Pubitemid 37254863)
36. Jaffa AA, Usinger W, McHenry MB, Jaffa MA, Lipstiz SR, Lackland D, Lopes-Virella M, Luttrell LM, Wilson PW. (2008). Connective tissue growth factor and susceptibility to renal and vascular risk in type 1 diabetes. J Clin Endocrinol Metab 93:1893-1900 . (Pubitemid 351656535)
37. Kawaguchi Y, Ota Y, Kawamoto M, Ito I, Tsuchiya N, Sugiura T, Katsumata Y, Soejima M, Sato S, Hasegawa M, Fujimoto M, Takehara K, Kuwana M, Yamanaka H, Hara M. (2008). Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population. Ann Rheum Dis 68:1921-1924.
38. Kemp TJ, Aggeli IK, Sugden PH, Clerk A. (2004). Phenylephrine and endothelin-1 upregulate connective tissue growth factor in neonatal rat cardiac myocytes. J Mol Cell Cardiol 37:603-606. (Pubitemid 38953387)
39. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT Jr, Rosenfeld RG. (1997). Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 94:12981-12986. (Pubitemid 27518462)
40. Kobayashi H, Hayashi N, Hayashi K, Yamataka A, Lane GJ, Miyano T. (2005). Connective tissue growth factor and progressive fibrosis in biliary atresia. Pediatr Surg Int 21:12-16. (Pubitemid 40169451)
41. Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, Kurabayashi M. (2007). Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 49:1120-1127. (Pubitemid 351664300)
42. Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, Suguta M, Yokoyama T, Tada H, Toyama T, Adachi H, Naito S, Oshima S, Nishida T, Kubota S, Takigawa M, Kurabayashi M. (2008). Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail 10:373-379.
43. Kono M, Nakamura Y, Suda T, Kaida Y, Kato M, Hashimoto D, Inui N, Miyazaki O, Kurasita S, Fukamachi L, Endo K, Ng P, Takehara K, Hamada E, Maekawa M, Chida K. (2010). N-terminal connective tissue growth factor (CTGF) is a potential biomarker of idiopathic interstitial pneumonias (IIPs) (Abstract). Am J Respir Crit Care Med 181:A1106.
44. Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, Janetzko A, Wiederholt T, Berg T, Müller T, Trautwein C, Gressner AM, Weiskirchen R. (2009). Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat 16:612-620.
45. Kubota S, Kawata K, Yanagita T, Doi H, Kitoh T, Takigawa M. (2004). Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem 136:279-282. (Pubitemid 39545786)
46. Kuiper EJ, de Smet MD, van Meurs JC, Tan HS, Tanck MW, Oliver N, van Nieuwenhoven FA, Goldschmeding R, Schlingemann RO. (2006). Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye. Arch Ophthalmol 124:1457-1462. (Pubitemid 44537147)
47. Kuiper EJ, Van Nieuwenhoven FA, de Smet MD, van Meurs JC, Tanck MW, Oliver N, Klaassen I, van Noorden CJF, Goldschmeding R, Schlingemann RO. (2008). The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. Plosone 3:e2675.
48. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, Friedman M. (1998). Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol 275:L365-L371.
49. Leask A, Abraham DJ. (2006). All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119:4803-4810. (Pubitemid 46017793)
50. Maeda A, Nishida T, Aoyama E, Kubota S, Lyons KM, Kuboki T, Takigawa M. (2009). CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem 145:207-216.
51. Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC. (2004). Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131:2137-2147. (Pubitemid 38702045)
52. Miyazaki O, Kurashita S, Fukamachi I, Endo K, Ng PS, Takehara K. (2010). Subtraction method for determination of N-terminal connective tissue growth factor. Ann Clin Biochem 47:205-211.
53. Mizutani M, Ito Y, Mizuno M, Nishimura H, Suzuki Y, Hattori R, Matsukawa Y, Imai M, Oliver N, Goldschmeding R, Aten J, Krediet RT, Yuzawa Y, Matsuo S. (2010). Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol 298:F721-F733.
54. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K. (1999). Role and interaction of connective tissue growth factor with transforming growth factorbeta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 181:153-159. (Pubitemid 29400382)
55. Morikawa H, Tamori A, Nishiguchi S, Enomoto M, Habu D, Kawada N, Shiomi S. (2007). Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension. Mol Med 13:240-245. (Pubitemid 47175033)
56. Narkewicz MR, Kasaragod A, Lucia MS, Pflummer S, Sokol RJ, Stenmark KR. (2005). Connective tissue growth factor expression is increased in biliary epithelial cells in biliary atresia. J Pediatr Surg 40:1721-1725. (Pubitemid 41625735)
57. Nguyen TQ, Goldschmeding R. (2008). Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm Res 25:2416-2426.
58. Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA. (2006). Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 29:83-88. (Pubitemid 44033436)
59. Nguyen TQ, Tarnow L, Jorsal A, Oliver N, Roestenberg P, Ito Y, Parving HH, Rossing P, van Nieuwenhoven FA, Goldschmeding R. (2008). Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy. Diabetes Care 31:1177-1182.
60. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM. (2004). Comprehensive gene expression profiles reveal pathways relatedto the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 101:14895-14900. (Pubitemid 39410771)
61. Nishioka M, Ogawa E, Kinose D, Haruna A, Ohara T, Ito I, Hoshino Y, Ito Y, Matsumoto H, Niimi A, Mio T, Chin K, Hirai T, Muro S, Mishima M. (2010). Lipopolysaccharide induced connective tissue growth factor gene expression in human bronchial epithelial cells. Respirology 15:669-676.
62. Pan LH, Yamauchi K, Uzuki M, Nakanishi T, Takigawa M, Inoue H, Sawai T. (2001). Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J 17:1220-1227. (Pubitemid 32717482)
63. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V, Gauthier JM, Ba N, Sobesky R, Ratziu V, Bedossa P. (1999). Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30:968-976. (Pubitemid 29458286)
64. Perbal B. (2004). CCN proteins: multifunctional signalling regulators. Lancet 363:62-64. (Pubitemid 38076928)
65. Phanish MK, Winn SK, Dockrell ME. (2010). Connective tissue growth factor-(CTGF, CCN2)-a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol 114:e83-e92.
66. Riser BL, Cortes P, DeNichilo M, Deshmukh PV, Chahal PS, Mohammed AK, Yee J, Kahkonen D. (2003). Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int 64:451-458. (Pubitemid 36871916)
67. Roach JP, Bruny JL. (2008). Advances in the understanding and treatment of biliary atresia. Curr Opin Pediatr 20:315-319. (Pubitemid 351670537)
68. Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Höppener JW, Goldschmeding R. (2006). Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol 290:F1344-F1354. (Pubitemid 43830759)
69. Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W, Weitz S, Schlingemann RO, Goldschmeding R. (2004). Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care 27:1164-1170. (Pubitemid 38579784)
70. Sánchez-López E, Rayego S, Rodrigues-Díez R, Rodriguez JS, Rodrigues-Díez R, Rodríguez-Vita J, Carvajal G, Aroeira LS, Selgas R, Mezzano SA, Ortiz A, Egido J, Ruiz-Ortega M. (2009). CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J Am Soc Nephrol 20:1513-1526.
71. Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K. (2000). Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 27:149-154. (Pubitemid 30058642)
72. Schieren G, Gambichler T, Skrygan M, Burkert B, Altmeyer P, Rump LC, Kreuter A. (2010). Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions. Am J Kidney Dis 55:1040-1049.
73. Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR 3rd, Carmichael DF. (2001). The low density lipoprotein receptor-related protein/ alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 276:40659-40667.
74. Shi Y, Tu Z, Bao J, Sun H, Wang W, Luo G, Li S, Li Y, Bu H. (2009). Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury. Scand J Urol Nephrol 43:390-399.
75. Slagman MCJ, Nguyen TQ, Waanders F, Vogt L, Hemmelder MH, Oliver N, Navis GJ, Goldschmeding R, Laverman GD. (2009). Sodium restriction, losartan, and hydrochlorothiazide reduce elevated urinary CTGF/CCN-2 levels in patients with non-diabetic proteinuria (Abstract). J Am Soc Nephrol 20:A620.
76. Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH. (2009). Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokine 47:37-42.
77. Tamatani T, Kobayashi H, Tezuka K, Sakamoto S, Suzuki K, Nakanishi T, Takigawa M, Miyano T. (1998). Establishment of the enzymelinked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun 251:748-752. (Pubitemid 28512782)
78. Tong ZY, Brigstock DR. (2006). Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor. J Endocrinol 188:R1-R8.
79. Wahab NA, Weston BS, Mason RM. (2005). Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 16:340-351. (Pubitemid 41725129)
80. Weitz SL, Usinger WR. (2003). Methods of assaying connective tissue growth factor. US patent (online) available at http://ip.com/ patapp/US20030113816.
81. Wynn TA. (2008). Cellular and molecular mechanisms of fibrosis. J Pathol 214:199-210. (Pubitemid 351160157)
82. Yilmaz S, McLaughlin K, Paavonen T, Taskinen E, Monroy M, Aavik E, Vamvakopoulos J, Häyry P. (2007). Clinical predictors of renal allograft histopathology: a comparative study of single-lesion histology versus a composite, quantitative scoring system. Transplantation 83:671-676. (Pubitemid 46569178)
83. Yokoi H, Mukoyama M, Sugawara A, Mori K, Nagae T, Makino H, Suganami T, Yahata K, Fujinaga Y, Tanaka I, Nakao K. (2002). Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 282:F933-F942. (Pubitemid 34654499)
84. Yoon PO, Lee MA, Cha H, Jeong MH, Kim J, Jang SP, Choi BY, Jeong D, Yang DK, Hajjar RJ, Park WJ. (2010). The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 49:294-303.
85. Yoshisue H, Suzuki K, Kawabata A, Ohya T, Zhao H, Sakurada K, Taba Y, Sasaguri T, Sakai N, Yamashita S, Matsuzawa Y, Nojima H. (2002). Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library. Atherosclerosis 162:323-334. (Pubitemid 34457938)
86. Yue L, Xia Q, Luo GH, Lu YP. (2010). Urinary connective tissue growth factor is a biomarker in a rat model of chronic nephropathy. Transplant Proc 42:1875-1880.
87. Zarrinkalam KH, Stanley JM, Gray J, Oliver N, Faull RJ. (2003). Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients. Kidney Int 64:331-338. (Pubitemid 36714188)
88. Zhang D, Wang NY, Yang CB, Fang GX, Liu W, Wen J, Luo C. (2009). The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis. Dig Dis Sci 55:767-774.
89. Zhang P, Shi M, Wei Q, Wang K, Li X, Li H, Bu H. (2008). Increased expression of connective tissue growth factor in patients with urethral stricture. Tohoku J Exp Med 215:199-206.